Dr Edmond Fernandes selected as Legislative Fellow by the US govt

Media Release
September 29, 2017

Mangaluru, Sept 29: Dr Edmond Fernandes, Founder & CEO, CHD Group and Adjunct Faculty, Dept of Public Health, KSHEMA, Nitte University has been selected as a Legislative Fellow which is a very prestigious fellowship supported by the US Department of state.

He is one among the 12 selected for this prestigious fellowship from across the nation and the only one from the state of Karnataka. The goal of this fellowship is to understand and establish networks among mid-level professionals in the US and India. The Fellows will be exposed to the working of the US Government Departments, interface with regard to public policy and relevant streams related to the core nature of their work.

Dr Fernandes will seek to build and strengthen Indo-US partnerships in terms of Public health and policy domains. While in the USA, he will be travelling to the states of Washington DC, Pennsylvania and then later to New York. Dr. Edmond Fernandes will be majorly working in the city of Philadelphia – where the declaration of Independence and the Constitution was signed.   

The Legislative fellowship will also focus on the structure of the US Government, the legislative processes, role of civil society and the impact of good governance on the lives of civilians. Dr Fernandes will also engage in civic leadership engagements and grass-root level activities while in the US and during the Professional Fellows Congress meet with other mid-level professionals and US Government officials. As part of the fellowship’s diplomatic mandates, he will host an American Counterpart during their visit to India. The Legislative fellowship is managed and implemented by World Learning Inc.

Dr Fernandes is also Member- Health Task Force, DDMA, government of Karnataka and has worked extensively in community empowerment programs in and around the country and across other nations besides enhancing the public health systems wherever the demand is. He leads CHD Group – Center for Health and Development which is a field based and field informed public health organisation which engages in public health risk reduction activities, advocacy, capacity building, monitoring and evaluation.
 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 3,2020

Mangaluru, April 3: A police officer in Sullia town of Dakshina Kannada district got injured on Friday after unidentified youth pelted stones at him.

The incident took place when the cop stopped them from entering into the state from Kerala in the view of nationwide lockdown. He was later administered medical aid.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 4,2020

Bagalkot, April 4: A COVID-19 positive patient passed away in Karnataka's Bagalkot on Friday, taking the total number of deaths in the state to four, informed the Deputy Commissioner of Bagalkot.

The total number of coronavirus cases in the country now stands at 2650 including 184 people who have been discharged or cured or migrated, and 68 deaths, as per the data provided by the Ministry of Health and Family Welfare.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 5,2020

Mar 5: The government on Thursday asserted that there is no shortage of raw ingredients or medicines in the country as it has taken various initiatives to tackle the challenge posed by the coronavirus outbreak.

All initiatives are also being taken to ensure that there is no impact of the disease in India, Minister of Chemicals and Fertilizers D V Sadananda Gowda said.

"There is no shortage of any APIs in the country. We have sufficient APIs (active pharmaceutical ingredients) and medicines in the country," he said.

Gowda was addressing the 5th international exhibition and conference on the pharmaceutical and medical industry organised by the Department of Pharmaceuticals, Gujarat government and industry chamber Ficci here.

For another three months there is no shortage for undertaking production in the pharma sector, he added.

"Our government has taken all initiatives to ensure that as far as our country is concerned the coronavirus should be stopped, and there is no hazard as far as this issue is concerned," Gowda reiterated.

Coronavirus is a challenge and "we should make all efforts that need to be taken..., " he added.

On Tuesday, India, the world's largest maker of generic drugs, restricted the export of common medicines such as paracetamol and 25 other pharmaceutical ingredients and drugs made from them, as it looks to prevent shortages amid concerns of the coronavirus outbreak turning into a pandemic.

Besides over-the-counter painkiller and fever reducer paracetamol, drugs restricted for exports included common antibiotics metronidazole, and those used to treat bacterial and other infections as well as Vitamin B1 and B12 ingredients.

A notification by the Directorate General of Foreign Trade (DGFT) had said the export of 26 active pharmaceutical ingredients (APIs) and formulations would require licence.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.